We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


SAW Instruments and ACOBIO K.K. Sign Exclusive Agreement to Distribute sam® Biosensors in Japan

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "SAW Instruments and ACOBIO K.K. Sign Exclusive Agreement to Distribute sam® Biosensors in Japan"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

SAW Instruments and ACOBIO K.K. have signed an exclusive agreement to allow ACOBIO K.K. to distribute SAW’s innovative sam® range of acoustic biosensors in Japan.

The news ties in with the Japanese launch of the newest member of the series, the high-end sam®X, at the 34th Annual Meeting of the Molecular Biology Society of Japan (December 13-16).

sam® systems provide a step-change in biosensor technology and applications, offering new capabilities for studying real-time kinetics on the surface of live mammalian cells.

The new sam®X expands the flexibility, power and throughput available via an increase in the number of analysis channels and new adaptable microfluidic routing.

ACOBIO K.K., which is owned by the Altair Corporation, was established in December 2011 to distribute innovative life science products in Japan.

Mr Eiji Takagi, former President of Biacore K.K. and new President of ACOBIO K.K., said: “Using our extensive experience in the pharmaceutical and biotechnology industries, ACOBIO’s mission is to make innovative life science technology and products from across the globe available for use by academia and industry in Japan. We are particularly pleased to have signed this agreement with SAW Instruments, as the company’s novel range of sam® biosensors open up new avenues for studying molecular interactions on the surface of mammalian cells.”

Unlike other cell-based detection platforms, sam® acoustic biosensors do not require any fluorescent labelling, are real-time rather than steady-state, and can use unfixed cells adhered to the sensor surface or in suspension, all while providing rapid analysis in the order of only a few minutes.

Dr Markus Perpeet, Managing Director of SAW Instruments, commented: “We are very pleased that our innovative sam® systems, which have already proven highly popular with researchers in Europe and the US, will now be available in Japan, and encourage Japanese researchers to see our new sam®X biosensor in action by visiting the ACOBIO K.K. booth at the Molecular Biology Society of Japan meeting.”

The new system offers increased throughput with two sensor chips, rather than the single chip of the sam®5 models, subsequently increasing the number of available channels to eight.

Using sophisticated fluidics, each channel can now be utilized independently (8 x 1) or via sequential combinations of 4 x 2, 2 x 4, or 1 x 8 channels, optimizing user workflow and facilitating flexible assay design.

Like the other members of the sam® family, the sam®X is ideal for measuring binding constants and kinetics at the surface of whole mammalian cells, as it generates highly accurate results significantly faster than similar equilibrium-based methods.